“Biomimética: Naturaleza replicada”
Year: 2015
“Robots del tamaño de virus”
El Periódico features an interview with Samuel Sànchez following the announcement last week that he has been awarded the Premio Fundación Princesa de Girona Investigación Científica 2015.
“Estudiamos las infecciones en el intestino de la bacteria E.coli”
Eduard Torrents, who heads IBEC’s Bacterial infections: antimicrobial therapies group, is the subject of an article in the Diari de Terrassa this week about his work earlier this year which identified a important factor in E. coli infection, opening the way to developing targeted drugs against the potentially deadly condition.
Eduard Torrents, who heads IBEC’s Bacterial infections: antimicrobial therapies group, is the subject of an article in the Diari de Terrassa this week about his work earlier this year which identified a important factor in E. coli infection, opening the way to developing targeted drugs against the potentially deadly condition.Samuel Sánchez wins FPdGi award for scientific research
IBEC group leader Samuel Sánchez is this year’s winner of the Premio Fundación Princesa de Girona Investigación Científica for his advances in in the field of nanotechnology.
Samuel’s work was recognised in particular for his pioneering design of self-propelled nanorobots that could improve the accuracy of drug delivery, as well as having potential environmental applications.
This year is the sixth edition of the national FPdGi Awards, which are given by the Fundación Princesa de Girona and which recognise the innovative and exemplary careers of young people between the ages of 16 and 35.
IBEC’s Annual Report 2014 now available
The English version of the Annual Report 2014 is now available to view online or download as a PDF.
In 2014, IBEC achieved, among other things:
– six Nature group papers, including a Nature Materials cover;
– 98 indexed journal papers in total, 77% of them in the first quartile;
– 12 PhD theses defended;
– two more ERC grants.
You can find all this and more in the Annual Report, which details the basic and translational research activities pursued by the institute in 2014, as well as the year’s news and scientific highlights, institutional alliances, tech transfer and clinical translation, and communications activities. A brand new section in this year’s edition covers IBEC’s Strategic Plan for the period 2014-2017 and the three areas of application in bioengineering.
A new mechanism in cell communication that promotes cancer metastasis
Pioneering international study supported by the Obra Social “la Caixa” opens new possibilities to control metastasis
Pioneering international study supported by the Obra Social “la Caixa” opens new possibilities to control metastasisAt a press conference at the Obra Social “la Caixa”’s Palau Macaya earlier today, Xavier Trepat, group leader at the Institute for Bioengineering of Catalonia (IBEC), Enric Banda, director of the department of Science and Environment of the Obra Social ”la Caixa”, and Josep Samitier, director of IBEC, described a study published in Nature Cell Biology which sheds new light on how to control metastasis.
“España entra en el proyecto europeo EIT sobre salud”
An article and interview with Josep Samitier in El Mundo presents EIT Health and the Spanish node.
Public event on IBEC research into light-controlled drugs
As Spain’s expert in optogenetics and optopharmacology, IBEC group leader Pau Gorostiza will be the star of the next “Diálogos por la Ciencia” event in Madrid next week.
As Spain’s expert in optogenetics and optopharmacology, IBEC group leader Pau Gorostiza will be the star of the next “Diálogos por la Ciencia” event in Madrid next week.An initiative of the Fundación “la Caixa”, “Diálogos por la Ciencia” are a new way of communicating science to the public, in which prestigious scientists with international recognition are interviewed live in front of a audience of the public by a renowned journalist.
ICREA research professor Pau, who heads IBEC’s Nanoprobes and Nanoswitches group, will talk about his work developing light-controlled drugs at the event in Madrid on 25th March.
New hope against growing threat of antibiotic resistance
The increasing prevalence of bacteria that are resistant to current antibiotics pose an escalating threat to human health. Now, researchers in Barcelona have identified a molecule with huge potential as a new type of antibacterial agent
Access to effective antibiotics is essential in all health systems. Their use has reduced childhood mortality and increased life expectancy, and they are crucial for invasive surgery and treatments such as cancer chemotherapy and organ transplants.
T5: Informativo Matinal, 17/03/15
